Longevixx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.5/10
Best for: one flat price at every dose across four GLP-1 formats, with a dietitian visit included
Price is where Longevixx scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not stated
Coaching
Included
No insurance needed · Vetted by our editors
Longevixx is a physician-led longevity practice run by Longevixx LLC out of Charlotte, North Carolina, offering compounded semaglutide, compounded tirzepatide, a GLP-1 microdose protocol and a daily oral GLP-1 alongside a deep peptide menu. One price covers every dosage, and the plan bundles medication, physician review, care coaching and a dietitian visit. Its public program list shows semaglutide from $139, tirzepatide from $149, the microdose from $129 and the oral option from $229 a month.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. How we make money
Vetted alternatives to Longevixx
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
from $139/mo (“starting at” price) · no insurance needed
Longevixx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $139/mo (“starting at” price) (Listed from $139/mo, billed every 30 days; down from $149 earlier this year.)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping · Coaching
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Longevixx
Each dimension is scored algorithmically from Longevixx’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
8.0/10At $139/mo (“starting at” price), Longevixx runs about 22% below the $179 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide). Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.7/10Longevixx offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
6.9/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
6.8/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
7.8/10Longevixx treats patients in all 50 states.
Support10%
7.3/10Coaching/dietitian access included.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Longevixx review
Last checked October 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the provider's public sign-up flow, stopping before payment
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $129–$229/mo across 4 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Longevixx
We walked Longevixx’s public signup flow in October 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Homepage and treatment pages lead with Check Eligibility; the treatment pages show no price, while the peptides page lists each GLP-1 program with a 'from' monthly price
- 2The eligibility flow opens at /eligibility with 'What would you like support with?' and four goal tiles
- 3Picking a goal moves to lifestyle questions, starting with 'How active are you usually?'; the public walk stopped here, before any health or identity answers
- Prices are public but easy to miss: they sit on the peptides page as 'from' figures, not on the semaglutide or tirzepatide pages
- Tirzepatide is now listed from $149, half the $299 shown on the post-quiz menu in August, so confirm the figure at checkout
- The quiz code includes a 'Woohoo! You're Approved' screen that leads straight into the priced treatment menu
- Ratings of 4.9/5 (homepage) and 4.8/5 (quiz) are shown with no review platform named, so they can't be checked
- The site states plainly that compounded medications are not FDA-approved
Longevixx customer support
- Phone
- (910) 621-1754
GLP-1 medications Longevixx offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Peptides Longevixx offers
Beyond GLP-1s, Longevixx also offers these peptides. Tap any for our evidence-based guide.
Pricing
Prices re-verified
Listed from $129/mo, billed every 30 days. The site does not name which GLP-1 molecule the microdose uses.
Listed from $139/mo, billed every 30 days; down from $149 earlier this year.
Listed from $149/mo, billed every 30 days; down from $299 earlier this year. Confirm the price on the post-quiz menu before paying.
Listed from $229/mo, billed every 30 days. The site does not name the molecule.
Ready to get started?
Plans and promotions change often, so check Longevixx's current pricing and active discounts before you decide.
What we like
- One price covers every dosage, so titrating up to a therapeutic dose does not raise your monthly bill
- Tirzepatide is listed from $149 a month, only $10 more than semaglutide
- The plan bundles medication, board-certified physician review, care coaching and a free dietitian visit
- Four GLP-1 formats including a lower-dose microdose protocol at $129 and a daily oral option at $229
- You are not charged unless a provider approves treatment, and shipping is free and discreet
- Unusually deep peptide menu alongside the GLP-1 programs, with each price listed
Watch-outs
- Treatment pages show no price; the figures appear only as 'from' prices on the peptides page and on the menu after the health quiz
- Cancellation terms conflict: 'cancel anytime', 30 days' notice before the next billing cycle, and 48 hours before the processing date
- Consultations and dispensed medication are non-refundable, and returned medication carries a $35 disposal fee
- No compounding pharmacy is named; the site refers only to state-licensed compounding pharmacies
- Terms require you to waive the right to have your prescription filled at a pharmacy of your choice
- Shows a 4.9/5 care rating on the homepage and 4.8/5 in the quiz with no review platform named
- The microdose and oral programs never say which GLP-1 molecule they use
Is Longevixx worth it?
The short version of what Longevixx offers is one flat price at every dose across four GLP-1 formats, with a dietitian visit included. It runs $139/month (“starting at” price) at every dose; there's no clean category median to weigh that against, but it's a published number rather than one you find out only after signing up. Its standout is a needle-free oral option for people who would rather not inject.
Beyond the medication itself, Longevixx offers a microdosing option. It also charges the same price at every dose and includes coaching or dietitian support.
How much Longevixx costs
Compounded semaglutide runs $139/month (“starting at” price), compounded tirzepatide runs $149/month (“starting at” price), and oral glp-1, daily, any dosage (no needles; molecule not named on the site) runs $229/month (“starting at” price).
Because Longevixx's headline figure is a “starting at” price, we don't set it against the roughly $179 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare Longevixx with the month-to-month prices of the alternatives below instead.
For a direct comparison, Live Vital runs semaglutide and tirzepatide from $130/month, so compare it with Longevixx before you commit.
Medications: what Longevixx prescribes
Longevixx prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the pair backed by the largest published weight-loss trials. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
Longevixx's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who Longevixx is best for, and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
- want coaching and follow-up built into the price already, instead of sold separately as an upsell.
- live anywhere in the US and want the certainty that your state is already covered.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
Longevixx treats patients in all 50 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
Longevixx is a reasonable telehealth GLP-1 option; weigh its pricing and coverage against the alternatives below before deciding.
The Bottom Line
Price is where Longevixx scores best in our breakdown.
Ready to start with Longevixx?
From $139/mo (“starting at” price). See current pricing and start your free consultation.
Longevixx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare Longevixx vs…
Longevixx scores7.5/10
Side-by-side pricing, medications and scores. Pick a matchup.
Longevixx vs Amazon One Medical
Amazon One Medical scores 8.5/10
Longevixx vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Longevixx review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Longevixx's current pricing
Plans from $139/mo (“starting at” price). Start your free consultation to check eligibility and today's price.